CVS Health schedules November 4 results for CVS Health stock

Published on 10/16/2026 at 15:27 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue hit USD 106.10 billion in the second quarter. CVS Health stock costs EUR 82.82 on October 16, 2026, up 1.35 percent versus the Xetra close.

Scheduled results and trading data

The company will discuss third-quarter results on November 4, 2026, at 8:00 a.m. ET.
Revenue reached USD 106.10 billion in the second quarter of 2026, up 7.30 percent year over year.
CVS Health stock costs EUR 82.82 at Lang & Schwarz on October 16, 2026 at 3:15 p.m. CEST, plus 1.35 percent versus the Xetra close of October 15, 2026.
The annualized dividend yield is 3.10 percent.

Aquarellbild eines amerikanischen Gesundheitszentrums mit Bäumen und Parkplatz in Pastellfarben — CVS Health Corp. Aquarell-Illustration zeigt amerikanisches Gesundheitszentrum im sonnigen Vorort, ISIN US1266501006, Illustration mit AI erstellt.

CVS Health announced on October 5, 2026 that it will discuss third-quarter 2026 results on November 4, 2026, at 8:00 a.m. ET, according to PR Newswire. CVS Health stock was trading at EUR 82.82 at Lang & Schwarz on October 16, 2026 at 3:15 p.m. CEST, plus 1.35 percent versus the Xetra close of October 15, 2026 (EUR 81.72).

Revenue reached USD 106.10 billion

CVS Health reported USD 106.10 billion in revenue for the second quarter of 2026, an increase of 7.30 percent from the year-earlier quarter, according to MarketBeat. The comparison gives the scheduled November report a clear operating benchmark, although the next release will determine whether that pace held into the third quarter.

The dollar range leaves room

On the NYSE, CVS was last at USD 92.58 on October 15, 2026 at 4:00 p.m. ET. The stock's 52-week range was USD 69.51 to USD 110.68, placing the home-market price 16.35 percent below the high and 33.19 percent above the low.

Valuation and upcoming dates

CVS Health had a market capitalization of USD 118.4 billion, a price-to-earnings ratio of 24.49 and a 3.00 percent trailing dividend yield as of October 16, 2026. A separate company report cited by MarketBeat listed an annualized dividend yield of 3.10 percent and an October 22, 2026 ex-dividend date. The next scheduled reporting date remains November 4, 2026, as stated by PR Newswire.

Comparison with peers

CVS Health Corp.: plus 1.35 percent, P/E 24.49, market capitalization USD 118.4 billion
Cigna Group (NYSE, USD): plus 3.19 percent, P/E 12.37, market capitalization USD 79.0 billion
UnitedHealth Group (NYSE, USD): plus 2.79 percent, P/E 23.21, market capitalization USD 365.0 billion

Trading stays above the Xetra close

The euro quotation remained above the Xetra close during the afternoon, while the US-listed price sat below its 52-week high. CVS Health stock was trading at EUR 82.82 at Lang & Schwarz on October 16, 2026 at 3:15 p.m. CEST, plus 1.35 percent versus the Xetra close of October 15, 2026 at EUR 81.72. The further course of trading is shown by the continuously updated real-time quote of CVS Health stock.